YZYBIO-B (02496): Shi Jian Elected as Employee Representative Supervisor

Stock News
Dec 31, 2025

Dr. Wang Tao has resigned from his position as Employee Representative Supervisor of the company for personal career development reasons, effective December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department, was democratically elected as the Employee Representative Supervisor for the second term of the Board of Supervisors on December 31, 2025. Dr. Shi's term commenced on December 31, 2025, and will expire upon the conclusion of the second term of the Board of Supervisors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10